Frequently Asked Questions about Regenerative Stem Cell Therapies
Because the stem cells exert a rejuvenating and regenerative effect locally on the organs and tissues that have been weakened or damaged by external or internal processes.
Regenerative stem cell therapies can be used to treat a variety of seemingly different diseases that have the same or similar mechanism of disease in common. Stem cells can regenerate weakened tissues and organs and can therefore be used to treat many diseases caused by organ or tissue deficiencies. Meanwhile there are a lot of studies worldwide in which stem cells are being used to treat heart diseases, diabetes, joint diseases, neurological and endocrine diseases, and many other degenerative processes.
Stem cell therapies have been in use for several decades in a few areas (such as in the treatment of leukemia), whereas in many other areas stem cell therapies are still in the clinical testing stages and are therefore considered as experimental therapies.
Unfortunately therapeutical usage of stem cells is heavily restricted in the EU. Nonetheless, if the patient consents to have his own stem cells isolated and reinjected in the same surgical procedure it is legal to do so. Other types of stem cell therapies are only to be performed in clinical trials.
Yes, in the therapy of leukemia. Stem cells are currently being researched in the treatment of other types of cancer but results are still pending.
All infections, currently most cancers, and any disease where no benefit from stem cells is to be expected.
Theoretically mesenchymal stem cells can develop into any type of mesenchymal cell, which has been shown in laboratory cultures. Here the micro-environment, as well as (artificial) growth factors play a decisive role in the differentiation of stem cells into adult cells. The surrounding tissue in which the stem cells are incorporated evidently controls what kind of cells (skin cells, fat cells, muscle cells, etc.) develop from them. New studies suggest that in treatment stem cells will not develop into ripe tissue cells but rather works by excreting cytokines that help to regenerate the defective areas in the targeted tissue.
Mesenchymal stem cells are incapable of uncontrolled growth if injected. Furthermore the tissue surrounding the implanted stem cells controls the stem cells to behave according to the necessity of the surrounding tissue.
No. Stem cell-assisted lipotransfer (CAL) is the procedure and Celution® is an extraction technique developed by the company Cytori. A patented device approved for use in the EU is employed for automating and standardizing the preparation of cells from body fat. Celution® is used in the Clinic DDr. Heinrich® as an alternative to the standard laboratory technique.
Primarily the age and the human embryonic tissue origin. Although embryonic stem cells possess a somewhat higher biological potential than adult stem cells, their use is not only ethically questionable but also linked to an elevated risk of malignant degeneration (cancer). For these reasons the use of autologous adult stem cells (mostly mesenchymal stem cells from fat or bone marrow) is recommended for patients. Even at an advanced age these cells – like sperm cells – have a very high biological potential.
No! Stem cell-assisted lipotransfer is therapy with adult autologous stem cells and is not to be confused with stem cell therapy with embryonic stem cells, which for ethical reasons and owing to a much-debated risk of side effects is not allowed in Austria.